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INTRODUCTION 
 Cancer oesophagus is the ninth most common gastrointestinal tract 
malignancy and among the most prevalent cancer worldwide. The oesophageal 
cancer are highly lethal malignancies. The overall survival from Oesophageal 
carcinoma is 13%. Unfortunately the incidence is rising in our country. It is 
well known for its marked variation by geographic area, ethnic group and sex. 
 Despite the understanding of the risk factors and cellular rearrangement 
associated with oesophageal cancer, the current treatment modalities has 
changed little and long term survival remains poor. The incidence of lower 
oesophageal and gastro oesophageal junction tumours are increasing recently 
due to gastro oesophageal reflux disease. 
 Mostly the newly diagnosed patients have either locally advanced 
disease or have distant metastasis at presentation. As with all other tumours, the 
outcome for patient with oesophageal carcinoma is associated with the stage of 
the disease at presentation. Still now no single modality can optimally stage the 
local disease and distant metastasis. The late presentation is due to the factor 
that symptoms usually occur after three fourth occlusion of the   lumen of the 
oesophagus and involvement of adjacent structures. Hence the management of 
these patients is a challenging problem. 
  Despite ongoing advances in chemo therapy and radio therapy 
oesophagectomy continues to play a vital role in the management of the patient 
with oesophagus cancers both as curative and palliative treatment. With 
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multimodal diagnostic and therapeutic approach it will be possible to improve 
the prognosis of the tumour. The depiction of carcinoma esophagus in one of 
the ancient Chinese literature was "One suffers in autmn and does not live to 
see the coming summer", is no more considered true, due to recent diagnostic 
and therapeutic advances that have improved the short term and to some extent 
the long term prognosis of these patient. 
 Also esophageal maglinancy is potentially curable disease with a good 
survival rate, provided it has been diagnosed and treated early before 
submucosal lymphatic spread and satellite nodules have occurred. 
 The selection of optimal operative procedure depends upon the extent of 
the disease and physiological status of the patient. Unfortunately no 
replacement organ able to replace a healthy oesphagus. Despite this, available 
replacement organ will make the patient to lead a reasonably good quality of 
life. 
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HISTORICAL BACKGROUND 
 Oseophageal carcinoma is not a new malady, having been described by 
the Chinese as a cause of "Dyspepsia" more than 2000 years ago. 
 "No patients with malignancy are more miserable than those suffering 
from unrelieved malignant obstruction of the oesophagus, because ultimately 
die of slow starvation" as described by Lymen A. Brewer III in 1980 has paved 
the way for many historical milestones in oseophagectomy for cancer. 
¾ First described in Western literaure by Galen in the 2nd century17. 
¾ Avicenna documented dysphagia due to carcinoma oesophagus in 
10th century. 
¾ The earliest descriptions of oesophageal surgery are provided by the, 
"Smith surgical papyrus" as early as 2500 B.C., whose recordings of 
the anatomic, physiological and pathologic aspects of the repair of 
the perforation of "Gullet" were unearthed by the American 
Egyptologist Edwin smith. 
¾ The first milestone towards esophagectomy begin in 1868 when 
Kussmal first passed a lighted tube through entire esophagus into the 
stomach, thus allowing for the first time, a direct vision of the 
esophageal lumen. 
¾ Surgery for oesophageal cancer began in 1877 by Czerny17. 
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¾ Torck credited with first resection of thoracic oesophagus in 1913. 
He opened the "thoracic door" performing the 1st successful trans 
thoracic excision of mid esophagus carcinoma28. 
¾ Martin Kirschner devised a technique, by which esophagus 
anastamosed with stomach after resecting it. He mobilised stomach 
after cutting most of its blood supply28. 
¾ First successful one stage resection for thoracic oesophageal cancer 
and reconstruction using whole stomach by Onsawe in 193317. 
¾ Trans Abdominal or trans thoracic oesophagectomy with 
oesophagogastrostomy was done in 1946. 
¾ 1954 Mahoney and Sherman reported colon replacement following 
total oesophagectomy. 
¾ Brain reported jejunum  interposition by 1965. 
¾ 1978, Orringer revised the technique of Transhiatal esophagectomy 
without thoractomy. 
¾ Currently multimodality treatment is under evaluation6. 
Epidemiology 
 Cancer of the oesophagus represent 1% of all cancers diagnosed in the 
united states and accounts for 2.1% of all deaths due to cancer. 
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 It accounts for 5.4% of all carcinomas of all digestive tract and account 
for 9.1% of all deaths due to these cancers. 
 Numerous geographic variation occurs in the incidence of Esophageal 
cancer throughout the world. 
 In Asia and Africa, esophageal carcinoma is much more prevalent and is 
6th most common cases of cancer death in Adult males. 
 Highest incidence in Northern China & Japan15. 
 The incidence of oesophageal carcinoma is uniformly high in the Indian 
subcontinent and in other countries, which fall within the, "Asian esophageal 
cancer belts" which have  common epidemiology17. 
 In India oesophageal carcinoma occurs more common in Kashmir 43-60 
per lakh population which falls in the cancer belt and in costal Karnataka, 
Orissa and North eastern states. Various common epidemiological factors are 
responsible for occurrence of oesophageal carcinoma in the Asian oesophageal 
cancer belt28. 
Common epidemiological factors 
• Occurrence of chronic esophagitis in the absence of reflux 
disease. 
• Consumption of hot beverages and the attendant possible thermal 
injury to the oseophagus mucosa (Dejong et al., 1974)17. 
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• Regular consumption of dietary items containing substantiate 
amount of N-nitroso compounds such as preserved fish and 
pickled vegetables24.  
• Dietary deficiency of Vit A, B12, Zinc Vit C, Vit E (Graham et 
al., 1990, Brown et al., 1998). 
In our madras city the observations are as follows (MMTR). 
 Cancer esophagus is among the top 4 cancers among male and 
top six cancers in females since 1982. Recently it ranks 4th among 
the malignancies noted in the males and 6th in the females (2002). 
 Incidence among males makes is two fold higher in ratio than 
females. 
 The cumulative risk of getting carcinoma esophagus in lifetime is 
more for males 
 Squamous cell carcinoma is the most commonly encountered 
malignancy in 86% next comes adenocarcinoma 5.8% 
 The incidence is more among 65 yrs. of age (age standard ratio) 
 Increase occurrence in lower 3rd followed by middle third. 
 Radiotherapy is afforded for more patients.  
 Of the total cases of malignancies encounterd, the incidence for 
carcinoma oesophagus is 5%. 
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SURGICAL ANATOMY 
 The oesophagus is a muscular tube approximately 25cm long occupying  
the posterior mediastinum and extending from the cricopharyngeal sphincter to 
the cardia of the stomach. 2 cms of this tube lies below the diaphragm15.  
 This tube is flattened anteroposteriorly and the lumen is kept collapsed. 
It dilates only during the passage of food bolus. It is anterior to vertebral 
column and posterior to the trachea. Upper end is closed by cricopharyngeus 
muscle lower and closed by lower oesophageal sphincter. 
Parts 
 1. Cervical oesophagus 
 2. Thoracic oesophagus 
 3. Abdominal oesophagus 
Constrictions 
 Normally the oesophagus shows 4 constrictions at the following levels. 
 1. At its beginning-15cm from the incisor teeth 
 2. Where it is crossed by aortic arch - 22.5cm from incisor teeth 
 3. Where it is crossed by left bronchus: 27.5cm from incisor teeth 
 4. Where it pierces the diaphragm - 37.5cm from the incisor teeth. 
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Arterial supply 
Cervical part : Inferior thyroid artery-direct, through collaterals, 
branches from common carotid and subclavian 
arteries. 
Thoracic part : Oesophageal branches of aorta, Bronchial arteries, 
ascending branch of left gastric and inferior phrenic 
artery . 
Abdominal part : Oesophageal branches of left gastric artery and 
branches from inferior phrenic arteries. 
Belsey's Artery : Communicating branch between inferior phrenic 
and left gastric arteries. 
Others : Bronchial arteries, Branches of left phrenic artery. 
Arterial supply 
The blood supply is extensive through intramural arterial collaterals. 
Virtually  entire oesophagus can be adequately perfused via the named vessels. 
All the major vascular trees that supply the oesophagus divide into minute 
branches, for some distance from the oesophagus. The capillary network extend 
into musculature and form an extensive capillary plexus into the submucous 
plane forming a `T' type configuration. Because of its rich blood supply, 
oesophagus can be mobilised to any extent and can still remain viable. Hence 
poor blood supply causing anastamotic leak is very rare. Great care must be 
exercised during the mobilisation of distal oesophagus beneath through the 
pleuroesophageal membrane because of inadvertent injury to the vessels. It is 
very important with left thoracotomy approach18. 
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Venous drainage 
 Cervical part  : Inferior thyroid veins 
 Thoracic part  : Azygos and hemiazygosveins 
Abdominal part : Veins which join left gastric vein which in 
turns ends in the portal vein. 
Venous drainage 
 It is similar to arterial system. They have an extensive intramural venous 
plexus in the submucosa. These veins drainout through the circular and 
longitudinal muscle layers into a series of veins on the outer surface of 
oesophagus. Venous drainage thus continuos via veins that parallel the arteries 
in a more or less segmental fashion. 
Nerve supply 
Cervical part : Branches from recurrent laryngeal branches 
(Parasympathetic), middle and inferior cervical 
sympathetic ganglion (sympathetic.) 
Thoracic part : Branches from vagi (para sympathetic), greater 
splanchnic nerves  from thoracic sympathetic chain 
(Sympathetic). 
Abdominal part : Branches from sympathetic-greater and lesser 
splanchnic nerves. 
Branches from parasympathetic - vagi 
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Lymphatic drainage 
 Cervical part : Deep cervical nodes 
 Thoracic part : Posterior mediastinal nodes 
 Abdominal part: Left gastric nodes 
Lymphatic drainage 
 A dense network of lymph vessels with in the mucosa and submucosa 
communicate freely with the lymphatic channels in the muscular layer with the 
periadventitial lymph nodes. 
 This rich submucosal lymphatic network is responsible for skip lesions 
and satellite  lesion that occur in area away from the primary tumour without 
much involvement of muscular layer. The absence of serosal coat also 
facilitates early dissemination of the tumour thereby necessitating a clearance 
of 10cm in order to give a adequate tumour free margins. 
 Based on the embryological development, lymphatic drainage like 
venous drainage, flow away from tracheal bifurcation. Because of this extrinsic 
lymphatic spread above and below it is appropriate to give a adequate clearance 
during surgery18. 
 Inspite of extensive mapping of lymphnode for patient with oesophageal 
carcinoma demonstrating areas of involvement there are overlaps at different 
levels within the esophagus. Hence proper staging is important. This is 
especially true for nodes below diaphragm20. 
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Histology 
1. Outermost  - Fibrous coat 
2. Muscular coat  - Upper 5% striated 
(inner circular) middle: 40% striated /smooth 
(outer-longtitudinal) distal 55% smooth 
muscle 
3. Submucous coat 
4. Mucous coat  - Stratified squamous epithelium 
     Last 3cm-columnar epithelium 
Embryology: 
 It starts to develop in the fourth week of embryonic development from 
the foregut immediately caudal to the primordial pharynx and extends to the 
fusiform dilatation in the foregut. Muscle develops from mesoderm. 
Anatomical specialities 
 1. Lacks serosa 
 2. Two different types of muscles-striated and smooth 
 3. Two different epithelium 
 4. Segmental blood supply 
 5. Only part of GIT-donot have meissner's plexus 
 6. Longtitudinal arrangement of veins and lymphatics. 
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Physiology 
 Swallowing is a complex series of events that have been divided 
radiologically into six regions. These types of contractions are seen  in 
oesophagoscopy. Primary peristalsis is progressive and triggered by voluntary 
swallowing. Secondary peristalsis is also progressive, but it is gradual by 
distension or contractions. Tertiary contraction are non progressive. 
Simultaneous contraction that may occur either after voluntary swallowing or 
spontaneous between swallowing. 
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AIM OF THE STUDY 
¾ To assess the modes of presentation 
¾ To evaluate the patient in details with the help of available 
investigations as best as possible. 
¾ To analyse Pre surgical optimisation. 
¾ To analyse available Surgical strategy. 
¾ To analyse Outcome of the surgical procedure. 
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METHODS AND MATERIALS 
Forty five cases of carcinoma oesophagus were treated in Kilpauk 
Medical College-Govt. Royapettah Hospital with Surgery as primary modality 
of treatment for cure and also palliative procedure. 
The duration of study of 3 years from June 2003 to April 2006. 
These cases  were studied from the time of admission till discharge and 
followed up till now in the out patient department. 
A detailed clinical history was made and thorough clinical examination 
was done before arriving at the diagnosis. The diagnosis was confirmed with 
the help of investigation available in our hospital. All details are meticulously 
recorded after review in the case sheets. Any treatment approach contemplated 
or executed was duly recorded. 
All variable pertaining to the patients investigation and treatment were 
recorded in preformed work sheets to ensure uniformity in recording and to 
eliminate any bias. 
All information was recorded in a master chart so as to enable early 
comparison and for critical analysis. The details of the patients and the 
procedure are given in the master chart. 
Methods adopted 
1. Clinical evaluation 
2. Investigations-Invasive and non invasive = UGI Scopy with biopsy, 
CECT Abdomen, Thorax, Bronchoscopy, USG Abdomen, Pelvis 
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3. Assessment of co-morbidity diseases  
4. Staging done accurately 
5. Treatment modality decided as per staging and physical status of the 
patients. 
Follow up  
1. General condition 
2. Improvement in swallowing capacity 
3. To look for evidence of anastomotic stricture 
4. To look for evidence of recurrence. 
5. Evidence of distant metastasis 
Depending upon post operative histopathological report post operative 
OP RT/CT given. 
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MODES OF PRESENTATION 
 Usually the patients with carcinoma esophagus presents with difficulty 
with swallowing as the main complaint. The duration is usually of shorter 
period and it progress from solid to liquid foods and finally to saliva. 
 The patients usually presents late because the difficulty with swallowing 
occurs only after occlusion of more than three fourth's of the lumen. Early 
presentation is very rare. 
 Some patients may present with retrosternal discomfort due to 
involvement of adjacent structures. 
 Some patient may present with cough white taking food due to 
occlusion of lumen or due to recurrent laryngeal nerve involvement. 
 Other modes are presentation may also be the following ways. 
 1. GORD 
 2. Anorexia 
 3. Loss of weight 
 4. Early satiety 
 5. Hoarseness of voice 
 But mostly more than 90% is associated with dysphagia. Based on the 
degree of dysphagia grading can be done. 
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EVALUATION 
 Almost 50% of cases are diagnosed outside and referred to our hospital. 
 In the evaluation process, it begins with the thorough clinical 
examination of the patient first. Associated co-morbid conditions are analysed 
in detail. 
 UGI scopy forms the gold standard initial investigation of choice as it 
provides virtual presentation and histopathological analysis. 
 The extent of disease and involvement of adjacent structures and distant 
metastasis is analysed with the help of CECT-Abdomen and chest. 
 Proper staging should be done with all the available investigations. 
Because staging can give the plan for treatment modality selected. 
 Apart from staging, the physical fitness should be analysed because it 
also determines the treatment outcome. 
 Inspite of the fact that almost all cases are presented in late stages in our 
setup, it is treated to provide a reasonably good cure or palliative treatment. 
 In many patients symptoms control and palliation are real therapeutic 
goals and quality of life should be take into consideration. 
Other evaluation modalities 
 EUS/MRI / PETScan / Diagnostic Laparoscopy / thoracoscopy. 
 18
PRE OPERATIVE OPTIMISATION 
 Preoperative optimisation is necessary to improve the outcome of 
surgery. Because most of the patient of oesophageal cancer are underweight 
and anaemic and have low body mass index or history of recent weight loss due 
to dysphagia. 
 These patients with nutrition deficiencies have high complications and 
mortality rates and morbidity rates following surgery. The effects of 
undernutrition are loss of immunity, delayed wound healing, loss of gut 
integrity, decreased muscles strength and delayed in post operative cure. It 
therefore seems logical that perioperative nutrition will improve outcome. 
 All patients admitted in the ward are thoroughly evaluated for anaemia 
and undernutrition. Patients are provided with acute special diet from the time 
of admission either orally if possible or thorough feeding jejunostomy at the 
earliest or through hyper caloric total parental nutrition for 7-10 days 
preoperatively 2500-3000 calories/day. 
 Anaemic patients are transfused with blood. Adequate respiratory 
exercises are given to improve post operative respiratory function. Stop 
smoking atleast 10 days prior. 
 Cardiac status should be thoroughly evaluated as the procedures are long 
and the patients cardiac condition should be suitable to withstand the 
procedure. 
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PREOPERATIVE NUTRITION ASSESSMENT 
Hb%, total proteins / serum-albumin / lymphocytes count 
/Anthoropometry. 
Respiration24 : FEV, 2 L or more 
   < 1.25L- poor candidate for surgery 
Cardiovascular24 : EF > 40% <40% increases cardiac risk for surgery.
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REVIEW OF LITERATURE 
Carcinoma oesophagus 
 It is the ninth most common cancer in the world6. It is common in 
tropical countries. In general it is a disease of mid and late adulthood with a 
poor survival rate6. The incidence of oesophageal cancer varies more than any 
other cancer. In recent years with an improved standard of surgical technique 
and perioperative care, substantial reduction in operative morbidity and 
mortality has been achieved. 
Etiology 
Dietary  : Pickled vegetables, preserved meat, salted 
dry fish, food contamination by fungus 
Micronutrient deficiency : Vitamin A, B12, C, E Beta Carotene. 
Alcohol 
Smoking 
Trace element deficiency : Cobalt, copper, Molybdenm, Zinc. 
 
Malnutrition 
Anaemia 
Human-Papilloma virus infection. 
Hereditary: 
 Tylosis 
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Nutrition 
 Worldwide nutrition deficiency have been implicated in the 
pathogenesis of oesophageal cancer. Generally poor nutrition was a positive 
predictor of risk for esophageal cancer. Deficiency of Vit A, B12, C, E and B-
cartotene is said to be one of the etiology28. 
Alcohol 
 Ethanol was extended to be causative agent in approximately 80% of 
cases24. Relative risk increases with the amount of consumption of the three 
varieties of liquors, quoted the incidence is more for liqour, intermediate for 
wine and less for beer28. 
 Hard liqour and home breaved alcohol are associated with increasing 
risk in India. In west 80-90% alcohol and smoking forms the etiology. 
Mechanism 
 metabolic activation of N-nitroso compounds. 
 decreased destruction of potential carcinogens 
 Increasing activation of potential procarcinogens 
Dietary 
1. Consumption of hot beverages is said to produce  injury to the 
mucosa forming a predisposing factor (Dejang, et al., 1987)28. 
2. Improperly preserved foods and salted food and salted dry foods are 
said to be the predisposing factors. 
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3. Betel chewing: Chewing of Betel nuts with or without lime said to 
increase the risk of squamous cell carcinoma by mechanical irritation 
and by the release of epoxides. 
Smoking 
 Contains polycyclic aromatic compounds and N-nitroso 
derivatives increases the incidence of atypia24. 
 Increase use of tobacco and increasing number of cigarettes said 
to increase the incidence24. 
 Increase duration of smoking is said to increase the risk 
 Ex-smokers have reduced risk when compared to current smokers 
and after 10 years the risk is similar to risk of non smokers. 
Predisposing conditions 
 1. Achalasia 
 2. Reflux esophagitis 
 3. Barrett's oesophagus 
 4. Radiation oesophagitis 
 5. Caustic burns 
 6. Plummer vinson syndrome 
 7. Lye corrosive stricture(5%)28 
 8. Chronic dysplasia 
 9. Ectopic gastric mucosa 
 10. Other aerodigestive malignancy 
 23
Sex Incidence 
 More common in males when compared to females15. However post 
cricoid growth in patients with Plummer Vinson syndrome  occur more 
commonly in females at a risk of 3:7 (Skinner et al., 1983). 
Age incidence 
 The highest incidence are found in the age groups between 40-60 yrs. 
The incidence begins in the adulthood increasing gradually6. But in western 
countries, the incidence is more in 60-70 yrs. Cancer in  female is reported 
more frequently in the age group of 30-50 yrs (Das et al., 1971). 
Site 
 Middle third : 50% SCC 
 Lower third : 33% AC 
 Upper third : 17% SCC 
Lower 3cm of oesophagus lined by columnar epithelium, so 
adenocarcinoma is common here 
Macroscopic types18: 
 1. Annular 15% - Schirrous, flat, diffuse, infiltrative 
 2. Ulceretive : 20% excavated, burrowing into the muscular layer. 
 3. Fungating - Cauliflower like 60% (protruded)  
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Histology 
Carcinoma15 
 Squamous : >90% SCC 
 Adenocarcinoma : 5-8% AC 
 Others : 2% 
 But nowadays increasing incidence of adenocarcinoma are reported 
(Blot et al., 1991). 
Squamous cell variation15 
 Verrucous carcinoma 
 Basiloid squamous carcinoma (adenoid cystic carcinoma) 
 Carcinoma sarcoma 
 Based on depth of invasion - Early and advanced form 
 Early     Advanced 
 Carcinoma in situ   Involvement of muscular layer 
 Superficial spreading 
 Intra mucosal   Involvement of periadvential tissue 
 Intra submucosal 
Adenocarcinoma variants 
 Muco epidermoid carcinoma 
 Adenosquamous carcinoma 
Others 
Oat cell carcinoma 
Melanoma 
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Sarcoma 
 Leiomyosarcoma 
 Rhabdomyosarcoma 
 Fibro sarcoma 
 Lymphoma 
Spread 
1. Direct - Lack of serosa favour local extensions 
2. Lymphatic spread - by permeation and embolization 
3. Blood spread - Liver, lungs 
4. Longitudinal spread - spreads along the submucosa and intramuscular 
lymph nodes for a distance 5-6cm from the primary tumour24. 
5. Radial spread - Radial diffusion into adjacent structures like aorta 
tracheobronchial nodes, recurrent laryngeal nerve. 
Factors responsible for early spread and aggressive behaviour 
¾ Lack of serosal layer 
¾ Proximity of vital structures 
¾ Extensive mediastinal lymphatic drainage 
Squamous cell carcinoma 
 It accounts for 90% oesophageal cancer. Occur throughout the length of 
oesophagus and equally common in the middle and lower third 60% & 30% but 
less frequent in the upper third. 
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 Arises from mucosa of oesophagus 
 Macroscopy: Fungating/ulcerating/infiltrative/polypoidal 
 Depending upon degree of keratinisation and cytological atypia the 
histological appearance can be well, moderately or poorly differentiated. 
 Sensitive to radiotherapy6. 
Adenocarcinoma 
 Increasing in incidence in recent time. Majority originate from Barretts 
epithelium following longstanding GORD15. More common in distal 
oesophagus and invades adjacent gastric cardia. Sequence of progression 
intestinal metaplasia-dysplasia-insitu carcinoma -invasive carcinoma . Appears 
as flat or raised patch or any one of macroscopic form.  
Predisposing factors28 
¾ Barrett's esophagus 
¾ Heterotropic islands of columnar epithelium 
¾ Submucosal glands of esophagus 
Barretts esophagus found in 12% of patients who undergo UGI scopy 
for GORD. Prospective evaluation has suggested that the incidence of 
adenocarcinoma is 40 times with Barretts esophagus when compared to general 
population24. 
 27
The overall prevalence of Adenocarcinoma at the diagnosis of Barretts 
oesophagus is  approximately 10%15. 
Microscopically most tumours are mucin producing glandular tumour. 
Prognosis is poor. Insensitive to RT. 
Classification of Oesophagogastric junctional tumours15 
Type I: Adenocarcinoma of distal oesophagus that usually arises from 
an area with specialised intestinal metaplasia of the oesophagus and may 
infiltrate the oesophago gastric junction from above. 
Type II: Cancer of the true cardia arising from the cardiac epithelium or 
short segments with intestinal metaplasia at the oesophago gastric junction. 
Type III: Subcardiac gastric cancer which infiltrates the oesophago 
gastric junction and distal oesophagus from below. 
Common symptomatology 
 Dysphagia   Cough on swallowing 
 Regurgitation  Dyspnea 
 Weight loss   Neck mass 
 Cough    Hemoptysis 
 Pain    Hematemesis 
Hoarseness of voice  Tarry stools 
Anorexia 
Progressive dysphagia : Most common symptoms for carcinoma 
oesophagus 85.4% 
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Functional grades  of dysphagia Incidence 
at diagnosis
Grade I  Eating normally 11% 
Grade II Regurgitation with meals 21% 
Grade III Able to take semisolids but unable to take solid food 30% 
Grade IV Able to take liquids only 40% 
Grade V Unable to take liquids, but able to swallowing saliva 7% 
Grade VI Unable to swallow saliva 12% 
 
Clinical signs 
 Anaemia  Palpable lump 
 Cachexia  Enlarged liver 
 Dehydration  Ascites 
INVESTIGATIONS 
Oesophagoscopy * Visualisation of entire oesophagus 
 * Site and extent of lesion 
 * Type of lesion 
 * Degree of occlusion 
 * Extent of spread 
 * Tissue biopsy can be taken 
Barium swallow * Double contrast barium swallow 
 * Degree of stricture 
 * Level of obstruction 
 * Length of the tumour 
 * Angulation of oesophageal lesion 
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 * Assessment of proximal stomach as a 
conduit for reconstruction after 
esophagectomy. 
 * Fluoroscopy guided films-early lesions. 
 * Sensitivity 74-97%17. 
CECT * Location of tumour 
 * Local tumour burden 
 * Lymph node involvement (accuracy 50%17) 
 * Invasion of adjacent structures (accuracy 
80%28) 
 * Mediastinal involvement 
    * Distant metastasis (accuracy 87-100%) 
(Normal CT oesophagus wall thickness 5mm) 
Less sensitive for lymphnode invasion detection. 
MRI 
No discredible advantage over CT in detecting either oesophageal 
spread of primary tumour or Regional lymphnode invasion. It can only 
delineate margin between adjacent esophagus and mediastinal fat. It can view 
axial, sagittal, coronal plane. 
EUS 
 Accurate estimation for T staging (70-80%)28 
 Lymphnodes invasion can be made out (accuracy 73-93%)17 
 FNA can be done 
 Can identify adjacent organ involvement 
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Pit falls 
 Tissue invasion >5cms-accuracy becomes less, 2) not useful to study 
intra abdominal lymph node involvement, 3) when lumen occluded, the EUS 
cannot be done to assess the extent because of limited  tissue invasion. 
PET 
 Non invasive 
 Detects primary, nodal and distant metastasis 
 Here mainly to detect distant metastasis 
Minimal invasive surgical staging 
 Video assisted thoracoscopy 
 Laparoscopy 
 Broncho scopy 
Thoracoscopy 
 Visualises the thoracic cavity 
 Biopsy from lesion 
 Adjacent structures involvement-can be made out diagnostic  
Diagnostic laparoscopy 
• Used for evaluation of patients with carcinoma of distal oesophagus 
• Biopsy from cardiac lesion can be taken 
• Peritoneal metastasis can be made out  
• Liver surface involvement can be made out 
• Lap ultrasonography - visualises nodes <3mm 
 31
 
Bronchoscopy 
• Especially done for upper and middle third tumours 
• Mobility of vocal cords can be assessed  
• Edema an erythema of airway can be made out 
• Mobile protrusion of posterior tracheal wall shows tracheal involvement. 
CXR: To look for aspiration pneumonia 
¾ Left lateral views show subcarinal involvement. 
¾ For anesthetic assessment 
¾ to work for metastasis 
Staging 
 Staging should be done with the help of investigation mentioned above. 
Staging of the diseases is essential to choose the best therapeutic options for the 
patient and for assessing tumour resectability28. Staging of the disease at the 
time of diagnosis in the single most important prognostic factor15. 
TNM Staging  Primary Tumour (T) 
Tx   : Primary tumour cannot be assessed 
To   : No evidence of primary tumour 
Tis   : Insitu carcinoma 
T1a   : Tumour invades lamina propria 
T1b   : Tumour invades submucosa 
T2   : Tumour invades muscularis propria 
T3   : Tumour invades Adventitia 
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T4   : Tumour invades adjacent structures 
Regional lymphnodes (N) 
Nx : Regional lymphnodes cannot be assessed 
No : No regional lymphnodes metastasis 
N1 : Regional lymphnodes metastasis 
Distant Metastasis 
Mx : Presence of distant metastasis cannot be assessed 
Mo : No distant metastasis 
M1 : Distant metastasis 
Stage Grouping 
Stage O  T1S NO MO 
State I   T1 NO MO 
Stage IIA  T2 NO MO 
T3 NO MO 
Stage IIB  T1 N1 MO 
T2 N1 MO 
Stage III  T3 N1 MO 
T4 any N MO 
Stage IV  anyT any N  M1   (AJCC) 
Treatment 
 Curative 
 Palliative 
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Curative 
 Curative efforts include surgery / chemotherapy, radiotherapy. But 
retrospective studies shows that no treatment modality alone has proved 
superior. Current modalities focused on radiotherapy and chemotherapy with or 
without surgery. Therapy for oesophageal carcinoma is influenced by the 
knowledge that in most of these patients local tumour involvement or distant 
metastasis precludes cure. Infact 85-95% have lymphnode involvement at the 
time of presentation. Less than 10% with lymphnodes-survive for 5 years. 
Palliative 
 It is appropriate when patients are too debilitated to undergo surgery or 
have a tumour that is unresectable because of extensive invasion of vital 
structures, recurrence of resected or irradiated tumour or metastasis. The goal 
of palliation is to use the most effective and least invasive measures possible to 
relieve dysphagia and discomfort to support nutrition and to limit complication. 
Depending on the perceived life expectancy, palliation includes dilatation, 
intubation, photodynamic therapy, radiation therapy with or without 
chemotherapy, surgery and laser therapy. 
Treatment modalities available 
 Surgery 
 Radio therapy 
 Chemo therapy 
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Surgery 
 Gold standard primary treatment for local and regional tumour of the 
oesophagus in resectable disease and in patients fit for major surgery15. Primary 
objective is to provide macroscopic and microscopic removal of tumour. 
Secondary objective is to provide palliation of dysphagia. Mostly 30-40% 
resectable. At operation a few are found to be inoperable and in some there is 
residual tumour after resection. Mortality rate is 5-10%. 
 There are numerous variation in how resection is performed in terms of 
approach, extent of lymphadenectomy and reconstruction. All this variation are 
variable according to the physical status and extent of the disease of the patient 
and surgeons preference. Recognition of the patients who may be at increasing 
risk of complication is important for several reasons. 
1. Rational of resection whether cure or palliation can provide a good 
quality of life. 
2. Surgical approach can be modified (Ex: Tranhiatal approach is best for 
patient in whom thoracotomy approach may be increasing morbidity due 
to COPD). 
3. Obtaining informed consent regarding procedure and complication. 
4. Stratification of risk enable comparative audit between individual 
events. 
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Surgical modalities available 
1. Standard esophagectomy 
2. Radical en block esophagectomy 
3. Minimally invasive esophagectomy 
4. Lymph adenectomy - three field 
Esophagectomy may be Transthoracic 
    Total thoracic 
    Trans hiatal 
    Radical enblock 
    Minimal invasive 
 Advantages Disadvantages 
Trans 
thoracic 
Standard resection 
Good visualisation for tumour and LN 
dissection  
Requires repositioning of patient 
Requires thoracotomy 
Less than maximal resection 
Thoracic anastomosis 
Trans 
hiatal 
No thoracotomy 
Cervical Anastamosis 
Maximal Reconstruction 
Anastamotic leak early management 
Learning curve is long and difficult 
Mediastinal LN dissection 
Thoracic complications need thoroctomy 
 
Choice of surgery17 
Resection 
Cervical oesophagus Pharyngolaryngoesophagectomy 
free jejunal transfer 
Superior mediastinal Split sterum oesophagectomy 
    Three phase oesophagectomy 
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Middle and Lower third 
 Lewis - Tanner operation 
 Trans hiatal oesophagectomy 
 Three phase oesophagectomy 
 Oesophagectomy - Left thoracotomy approach 
Cardiac 
 Trans hiatal oesophagectomy 
 Esophagectomy - Left thoraco abdominal approach 
 Esophagogastrectomy - Abdominal right chest approach 
 Abdominal gastrectomy 
Bypass 
 Kirschner gastric bypass 
 Colon bypass 
 Jejunum bypass 
Reconstruction 
 Organ : Stomach 
   Left colon 
   Jejunum 
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Organs 
selection 
Advantages Disadvantages 
Stomach Single anastomosis 
Reliable blood supply 
Adequate length 
Convenient location  
Long suture lines 
Acid production 
Aperistalsis 
Diameter mis match 
Jejunum Best diameter match 
Peristalsis 
No acid production 
Preservation of gastric reservoir 
Multiple anastomosis 
Least reliable blood supply 
Inadequate length 
 
Left colon No acid production 
Preservation of gastric reservoir 
Adequate length 
Multiple anastomosis 
Least reliable blood supply 
 
 
Palliative bypass 
 1. Reversed gastric tube 
 2. Gastroescophagectomy proximal to the tumour 
 3. Colon bypass 
 4. Jejunal bypass 
Post operative complications18 
Pulmonary  : Pneumonia, ARDS 
Cardiovascular  : Myocardial infarction arrhythmia  
Gastrointestinal        :         Anastomotic leak, gastric stasis or outlet obstruction 
Infection  : Emphysema, subphrenic Abscess 
Others   : Vocal cord palsy, chylothorax 
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Radiotherapy 
1. Primary radiotherapy 
2. Preoperative radiotherapy 
3. Postoperative radiotherapy 
4. Preoperative chemo radiotherapy 
5. Postopeative  chemo radiotherapy 
6. Brachy therapy (radiotherapy) 
7. Palliation  
8. Primary chemo radiotherapy 
 Primary RT given if the lesion is <5 cm non obstructing, non 
circumferential. Dose : 60-64 Gy at 1.8-2.0 Gy/day. 
 When chemo radiotherapy is use: The standard RT dose is 50Gy. 
External RT can improve swallowing function in a significant proportion of 
patient. Radiation alone improves dysphagia in approximately 46-84% of 
patients. Radical RT-dose 50-60 Gy, delivered in 25-30 fractions of 200 each. 
 Pallative RT- 40-50 Gy, Aim is to slow down tumour growth, to palliate 
dysphagia and pain. Dysphagia improves in 50-80%, improves after 1-3 weeks. 
Radiotherapy : External beam radio therapy (EBRT) 
    Brachy therapy : irridium192 
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EBRT releives dysphagia in approximately 80% of patient who undergo 
therapy. Mostly recurrence occurs within 6 months after radiotherapy is 
completed. 
Pain relief may improve with increasing dosage. Intracavitary RT does 
not effect the radiosensitive adjacent structures-lung, spinal cord. Which are 
affected by EBRT. This therapy is also desirable for palliation in patients who 
have maximum cure by EBRT but limited because of side effects. 
Fractionating the dose of radiotherapy may increase the tolerance and 
effectiveness. Dysphagia free survival can last upto 12 months in 20-40% of 
patients. 
Chemotherapy 
¾ Preoperative chemo radiotheray 
¾ Postoperative chemo  radiotherapy 
¾ Pre op chemo therapy 
Drugs used 
 5FU / Cisplatinum / Mitomycin / bleomycin / Vinblastine / vincrintine 
a. Kies et al. CDDP 100mg/m2 D1 and 5FU 1000mg/m2 on Day 1-
10 repeat every 3 weeks for 3 cycles. 
b. Bleiberg et al. - CDDP 100mg/m2+5 FU 1000 mg/m2 as a 
continuous infusion Day 1-5 repeated every 3 weeks for 3 cycles. 
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c. Levarel and Pouligum et al., 1998 5 FU 1000mg/m2 infused over 
24 hrs during 5 days CDDP given either as one dose of 
100mg/m2 or as 20ng/m2 over three hours for 5 days. 
Palliative procedure 
• Photodynamic therapy 
• Laser canalization 
• Surgical byepass 
• Electro coagulation 
• Ethanol injection 
• Intubation 
• Dilatation 
• SEMS-Self expanding metallic stents 
• Brachytherapy 
Photodynamic therapy 
 A photosensitive agent such as dihematoprophyrin ether given 
intravenously and after 2-3 days this agent get retained in the tissue in a much 
higher concentration15. Then a low power laser system that produces red light is 
delivered to the tumour by a flexible endoscope. The photosensitiser assess the 
red light and produces oxygen radicals to destroy the tumour. Two to three 
days after therapy UGI scopy repeated necrotic tumour tissue removed. This is 
repeated monthly. Complications- Fistula formation, aspiration pneumonia, 
Edema of face and head 
Laser therapy 
¾ Endoscopic Nd: Yag laser therapy can be used for palliation15 
¾ It is expensive form of treatment 
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¾ It vaporises tumour tissue and reduces the obstruction 
¾ Sequential dilation or single treatment. 
Indications 
1. Tumour size <5cm 
2. Fungating polypoidal tumours 
3. Non infiltrating 
4. Non circumferential 
5. Non stenosing tumour 
Dilatation 
 Dilatation of malignant strictures for palliative dysphagia and to allow 
evaluation. Unfortunately relief is measured only in weeks. Patients with high 
grade malignant strictures are present with advanced stages. Hence dilatation 
done guardedly15. 
Stents 
 Positioning of a stent between the obstruction in oesophagus to alllow 
luminal patency primarily to control saliva and secondly for nutrition. The 
stents are flexible and are constructed in two layers of super alloy6,15 meshed 
wire with a layer of silicon between them. The silicon sandwiched between the 
layers delays tumour in growth through the holes in the wire mesh. Placement 
under LA or GA, stricture dilated to 42-45 French. Once inserted and 
expanded. The flanges at the end are anchored to the wall of the oesophagus. 
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 Patient notes chest discomfort following insertion due to expansion. The 
insertion of SEMS does not preclude further treatment with chemotherapy and 
Radiotherapy. 
 Average survival after palliative intubation for oesophageal carcinoma is 
less than 6 months. This method is also suitable for malignant tracheo 
esophageal fistula to occlude it and provide and oral alimentation6. 
SEMS 
Types Internal diameter 
Oesophageal 16mm 
Ultra flex15 17mm 
Wall stent 18mm 
Z stent 18mm 
 
Advantages 
1. Non collapsible 
2. Reduces tumour in growth 
3. Less risk of migration 
4. Deliver radial outward force 
Intubation 
1 Atkinson tube 
2. Celestin tube-Soutter tube 
3. Monsseau barbin tube 
 43
Intubation 
 Endoscopic dilatation and intubation has been successful in providing a 
temporary relief in patients with advanced cancer with short life expectancy. 
Peroral dilatation of oesophagus was done in the part with Ederpaston dilators 
which provide symptomatic temporary relief. Recently used tubes are 
mentioned above. 
BICAP Tumour probe 
 Bicap electrocoagulation is a recent and inexpensive technique which 
allows the tumour to be electrocoagulated at 1800 to 3600 by means of tumour 
probe15. 
Feeding gastrostomy and jejunostomy 
 Should be limited only to situations when there is no other therapeutic 
alternative since they do not allow oral feeding and actually worsen the patients 
quality of life. 
Terminal events in carcinoma esophagus 
1. Cancer Cachexia 
2. Sepsis, mediastinits 
3. Immuno suppression 
4. Malignant tracheo asophageal fistula 
5. Erosion into major blood vessel bleeding. 
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ANALYSIS OF STUDY 
AGE INCIDENCE 
Age Male Female Total Percentage 
<30 2 - 2 4.6 
30-40 2 4 6 13.3 
40-50 11 4 15 33.3 
50-60 10 1 11 24.4 
>60 10 1 11 24.4 
Total  100 
 
 The cases recorded in this study are between 30-70 years. Only 2 cases 
occurred less than <30 years. The age incidence noted in females are 
comparatively earlier when compared to males. The age incidence correlates 
with the literature. Highest incidence among 40-50 yrs. Above 50 yrs. the 
incidence remains same.  
SEX INCIDENCE 
Sex Total No. of cases Percentage 
Male 35 77 
Female 10 23 
Total 100 
 
 Among the studied case increase incidence found among male patients 
which correlates with literature. But Plummer Vinson syndrome which is said 
to be predisposing factors is common in female. 
Here the ratio of incident between the male and female is about 2.5:1 (M:F).
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PREDISPOSING FACTORS 
predisposing factors Total No. of cases Percentage 
Smoking(s) 40 89% 
Alcohol (a) 30 67% 
S+A 28 62.2% 
Non alcoholic smoker 2 4.6% 
Non smoker alcoholic 3 6.6% 
GORD 4 8.8% 
Non alcoholic & smoker 4 8.8.% 
 
 Among the patients studied smoking and alcohol forms a major 
predisposing factors. GERD forms the predisposing factors for the GE junction 
tumours. Almost all cases study alcohol uses takes tobacco (Smoking) along 
with it. The relative risk for getting the malignancy in smokers in 8 times 
compare to normal individuals. 
MODE OF PRESENTATION 
Symptoms Total No. of cases Percentage 
Dysphagia 43 95 
Weight loss 20 44.4 
Retrosternal discomfort 7 15.5 
Pain 20 44.4 
Hoarseness voice 2 4.6 
Cough 2 4.6 
Others 2 4.6 
 
 Almost all cases are presented with dysphagia. The other mentioned 
symptoms are associated with dysphagia. Only 7 cases presented primarily as 
symptoms of Retrosternal discomfort. Early the approach of the patient will 
help to diagnosis the condition and provide the way for cure. 
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 Two cases presented in a acute manner. First case presented with UGI 
bleed, for which emergency surgery done. Second one is due to perforation 
occurred during dilatation of stricture. 
GRADING OF DYSPHAGIA 
Dysphagia Total No. of cases Percentage 
Solid 20 44.4 
Semisolid 23 51.1 
Liquid 2 4.5 
Saliva - - 
Nil - - 
 
 Most of the cases presented with dysphagia for semisoliddiet. It occurs 
when the occlusion is about  half the lumen of oesophagus. Only few cases 
reported with difficulty in swallowing liquids. No cases reported with difficulty 
in swallowing saliva. 
 CO-MORBID CONDITIONS 
Co-morbid diseases Total No. of cases Percentage 
Diabetic mellitus 3 6 
CAHD 6 13.3 
Pulmonary diseases 6 13.3 
Anemia 15 33.3 
 
 As most patients are elderly the occurrence of age related diseases are 
common. This age related diseases, further aggravate the preexisting disease 
and delay the preoperative optimisation. Preoperative respiratory exercises are 
necessary to improve the post operative outcome. Pre operative anaemia should 
be corrected by pre operative transfusion to reduce post operative morbidity. 
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HISTOPATHOLOGY 
Histopathology Total No. of cases Percentage 
Squamous carcinoma 27 60 
Adenocarcinoma 16 35.5 
Others 2 4.5 
 
 Squamous carcinoma said to be the most noted malignancy among the 
cases studied which correlates well the literature. In our study the incidence of 
adenocarcinoma is increasing is noted which also correlate well with the 
literature. 
Pre-operative stay Total No. of cases Percentage 
< 10 days 4 8.8 
< 20 days 20 44.6 
< 30 days 16 35.5 
< 40 days 5 11.1 
> 40 days - - 
 
 The average duration of stay pre operatively is about 15-20 days as most 
of the patients are coming late with increase burden of disease, the 
investigation and pre operative preparation should be done as early as possible. 
Longer the duration of preparation will further aggravate the disease process. 
Aim to be motivated to start the early treatment. 
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Procedure performed Post op. outcome Remarks 
Oesophgogastrectomy 34 75.5 
Palliative coloplasty  1 02.2 
Non therapeutic laparotomy 10 22.3 
  
 Oesophagogastrectomy is most common surgery performed for 
oesophageal carcinoma. Stomach form the commonest organ of replacement 
with less post operative morbidity and mortality and a good quality of life. 
Inspite of effective pre operative evaluation 10 cases posted for definitive 
procedure can not be proceeded because of intra operative finding. In two more 
cases tumour broken during the procedure which resulted in positive margin 
which needed post operative radiotherapy and chemotherapy. One case there is 
extensive blood loss which is replaced. The average loss of blood during the 
procedure is above 750 to 1000ml. Nowadays it is less, we don't transfuse 
routinely unless it is necessary. One case develop anastomotic leak because of 
extensive adhesions which resulted in microscopic presence of malignancy. 
Coloplasty done in one case as a bypass procedure. One case pre operative 
radiotherapy given and taken for surgery. But intra operative course is stormy 
due to extensive peri oesophagitis. 
Post op. stay  Total no. of cases Percentage 
<10 day 10 22.2 
>10 days <20 25 55.6 
>20 days <30 10 22.2 
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 The average duration of stay post operatively is about 10-15 days. With i 
improve pre operative evaluation and good technical skills and good post 
operative care the duration can be minimised. 
Site Total no. of cases Percentage 
Upper - - 
Middle 25 55.55 
Lower 20 44.45 
 
 The incidence is more in middle third of oesophagus which correlates 
well with the literature. Next comes the lower third malignancies, the incidence 
of which increasing off date due to GORD. We did not encountered any upper 
third malignancy in this duration of study. The policy of the department is to 
consider non-surgical options for upper third malignancies. 
Post operative complications Total no. of cases Percentage 
Wound infection 2 4 
Anastamotic leak 4 8 
Respiratory complications 4 8 
Cardiac complications 4 8 
RLN-palsy - - 
Anastomotic strictures - - 
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 Mostly trans hiatal route is preferred for surgery. Thoracotomy done in 
four cases due to difficulty in mobilising the tumour and due to the location of 
the tumour. 
 Almost all cases of gastric pull up underwent pyloroplasty as a routine. 
We preferred mostly midline abdominal incisions and a left neck incision for 
anastamosis. 96% cases are started with feeding jejunostomy on the 3rd post 
operative day. Average duration for beginning of oral feeds on 5th post 
operatively. It is delayed in 2 cases because of suspicion of neck leak. 
 Inspite of effective pre-operative evaluation, about 9 cases of posted for 
definitive procedure deferred because of intra operative findings of 
inoperability. They are: 
 1. Involvement of aorta 
 2. Carinal involvement 
 3. Peritoneal metastasis 
 4. Extensive pleural involvement  
   5. Pancreatic involvement 
 
 Hand sewn neck anastomosis is equally found to be effective like 
staplers. Morbidity is less with hand sewn anastomosis. Less evidence of neck 
leak with hand sewn anastomosis. End to side neck anastomosis which is 
practiced in our procedures are associates with less post operative morbidity 
and good quality of life post operatively. 
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DISCUSSION 
 Esophageal carcinoma forms the second most common tobacco related 
cancer next to oral cancers. With peak age incidence between 40-60 years. And 
ratio between male and female incidence is 2.5. 
 The incidence is also more common among low socio economic status 
and alcohol and smoking forms the major etiological factors. 
 Dysphagia forms for the most common presenting complaints. 
Squamous cell carcinoma forms the most common type of tumour studied. 
 As the cure of the disease is strongly associated with the stage of the 
disease at the time of presentation, the management varies. 
 As most of the patients are presenting late in carcinoma esophagus, the 
management of the disease becomes a challenge to the treating surgeon. 
 Based on adequate an appropriate investigation the disease staged. The 
benefits and pitfalls of the treatment modalities are analysed adequately. Before 
deciding the treatment, the physical status of the patient is analysed. Age of the 
patient which was said to be a relative contra indication is not taken into 
consideration now. 
 In our study, there are various factors which delayed the planned  
modality of treatment. This is especially true when the patients are prepared for 
surgery. 
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 Inspite of multiple investigation available, it is some times not possible 
to stage of disease accurately. It is found out because the case posted for 
definitive procedure are deferred due to intra operative finding. 
 Apart from that not all modalities are available in a single institution and 
the cost factor is a limiting factor. 
Stomach form the best organ of reconstruction with less post operative 
complications and improved quality of life in the post operative period. 
The selection of palliative treatment are 
¾ Advanced stage of disease 
¾ Poor general condition 
¾ Patient not willing for surgery 
Surgery as a treatment modality depends on  
• Site of tumour 
• Burden of tumour 
• Histopathological evaluation  
• Stage of the disease 
• Extent to which it provides either cure or palliation 
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Oesophageal carcinoma 
 A curable and preventable disease. Best way to cure is to treat it early. It 
can be identified by : 1) active screening of high risk patients; 2) Screening for 
chronic smoker/tobacco/Alcoholic patients; 3) Evaluation the patient early with 
dyspepsia; 4) Creating public awareness about the disease. 
 No disease is adequately treated until it is prevented from future 
occurrence. The problem of oesophageal carcinoma is tackled by improving the 
public awareness about the demerits of smoking and early evaluation for 
dyspepsia and adequate early reporting to the speciality centre nearly. 
 Now the evolving investigations will provide adequate staging when 
used in combination. The pitfalls of one investigation is nullified by the other.  
But cost is the limiting factor. 
 Recently the evolving multimodality treatment is said to improve the 
quality of life in patients with oesophageal cancers. 
Knowledge is never complete, but we strive to make it more so. 
Auditing to improve clinical practice is similar to this. Perfect practice is never 
achieved, but the audit process gives us a systemic methods of striving towards 
perfection. 
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"Surgery without audit is like playing cricket without keeping the score" 
- H.B.DEVLIN. 
Here the audit cycle which compared with the standard revealed the 
above findings. 
One of the major considerations in the plan of operation is the site of 
tumour, after resection what is the level of anastamosis required to obtain an 8-
10cm segment of normal esophagus proximal to the carcinoma. 
Unfortunately, in more than 75% of patients with carcinoma of 
oesophagus, local tumour invasion or distant metastasis makes a curative 
resection impossible. Therapy for most of these patients is therefore palliative. 
Palliation mainly relives the difficulty in swallowing and pulmonary sepsis 
from aspiration of food and saliva. 
Palliative resection in these patients with acceptable risk remains a 
valuable means of treatment. Although survival is not greatly prolonged, the 
ability to continue oral intake maintains hydration and improves nutrition. 
Although cure of oesophageal carcinoma is seldom achieved by any of 
the treatment currently available, surgery provides the most efficient and 
expedited palliation in these patients. 
Ability to swallow comfortably for 12-24 months is generally achieved 
with oesophageal resection and reconstruction. 
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The leading cause of mortality after these operations is respiratory 
insufficiency which considers thoracoabdominal operation in a debilated 
patients and sepsis from an intrathoracic anastomotic leak are avoided by 
transhiatal oesophagectomy with a cervical oesophagogastric anastamosis. 
By positioning the oesophageal substitute in the posterior media stinum 
in the original oesophageal bed, one utilises the shortest and most direct route 
between neck and abdominal cavity. 
Should an anastomotic stricture develop, subsequent dilatation is much 
easier when one does not have to contend with the anterior angulation of the 
cervical esophagus, which has been anastomosed to a retrosternal graft. 
Because of the stomach's resilience and excellent blood supply, it remains the 
best organ for esophageal replacement. By resecting the entire intrathoracic 
oesophagus, regardless of the level of carcinoma and by performing cervical 
oesophageal anastomosis, the surgeon minimizes the risk of tumor recurrence 
along the suture line. Postoperative gastroesophageal reflux is seldom a 
problem, and if an anastomotic disruption does occur, it is easily managed with 
drainage and local wound care. We believe that transhiatal oesophagectomy 
with cervical oesophagogastric anastomosis, performed through an upper 
abdominal and left cervical incisions, provides the best palliation for 
oesophageal carcinoma currently available with the least possible operative 
morbidity. 
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REFERRED QUOTES 
¾ The most important risk factor for carcinoma esophagus in 
developing countries-cigarette (IARC: 1986) and alcohol (IARC, 
1988). 
¾ Day and Monoz in 1982 and Sehottenfield 1984 have shown an 
association between oesophageal carcinoma and low socio economic 
status. 
¾ Low initiate of fruits particularly citrus fruits and vite intake have 
been respectively associated with increasing risk of esophageal 
carcinoma (Dacerti et al. 1981). 
¾ Deficiency of various mineral elements such as Se, Zn, Mo also have 
be cited as possible etiologic factors. The deficiency are believed to 
make the susceptibility to the carcinogenic effects of exogenic 
factors (Francheschi et al., 1990). 
¾ Risk of tobacco use appears to increase with the number and duration 
of usage - (Tayns et al, 1979; Ross et al., 1982; Ya et al., 1988). 
¾ Elderly patient (Perachie et al., 1998) length of the tumour and 
associated child A-Liver cirrhosis (Feluk et al., 1987) as not 
considered contra indication for surgery. 
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CONCLUSION 
 Most common among males. Most common between 40-60 yrs 
age. 
 Squamous cell carcinoma forms the most noticed malignancy. 
 Increasing incidence of Gastroesophageal junction tumour due to 
increasing incidence of GORD. 
 UGI scopy and CECT are gold standard to asses local and distal 
burden of disease. 
 Combinations of investigations will accurately stage the disease 
to avoid unnecessary surgery. 
 Surgery forms the best and most efficient cure and palliative 
mode of treatment. 
 Preoperative optimisation is necessary to reduce post operative 
morbidity and mortality. 
 Stomach is the best organ of oesophageal replacement. 
 Transhiatal esophagectomy with cervical esophagogastric 
anastamosis provides the best palliation for esophageal carcinoma 
currently available with least possible operative morbidity. 
 Surgical options according to the intra operative findings and 
surgeon preference. 
  
ABBREVIATIONS 
A  - Alcoholic 
AC  - Adenocarcinoma 
CT  - Chemotherapy 
 CAHD - Coronary artery heart disease 
COPD - Chronic obstructive pulmonary disease 
DOA  - Date of admission 
 DOS  - Date of Surgery 
DOD  - Date of discharge 
D  - Dysphagia 
DM  - Diabetis mellitus 
GEjn  - Gastro esophageal junction 
GORD - Gastro oesophageal reflux disease 
IHD  - Ischemic heart disease 
Lap  - Laprotomy 
Mid  - Middle third 
N  - No evidence of extensive metastasis forming 
contraindication for surgery. 
OGA  - Oesophagogastric anastamosis 
RD  - Retrosternal discomfort 
RFD  - Reflux disease 
RT  - Radiotherapy 
SCC  - Squamous cell carcinoma 
S  - Stromach 
S  - Smoker 
THO  - Transhiatal oesophagectomy 
TTO  - Transthoracic oesophagectomy 
WL  - Weight loss 
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PROFORMA 
 
Name   Case No.  Diagnosis  Ward 
Age   DOA     
Sex   DOS   Staging 
IP No.   DOD   Plan 
 
Presenting complaints 
 
1. Dysphagia 
2. Weight loss 
3. Pain 
4. Regurgitation 
5. Hoarseness of voice 
6. Cough 
7. Retrosternal discomfort 
 
Past History  
 
  APD    Gastric surgeries 
  Corrosive ingestion  Endoscopic procedure 
  Irradiation 
 
Personal History 
 
Appetite 
Weight loss 
Alcohol   Duration  Type  Amount 
Smoker   Duration  Number Type 
Betel nut 
Veg/Non-Veg  Smoked food  preserved food 
 
Treatment history  UGI scopy 
    Previous surgery 
 
General Examination 
 
 Nourishment 
 Performance status 
 Pallor 
 Icterus 
 Clubbing 
 Cyanosis 
 Pedal edema 
  
 Lymphadenopathy 
 
Vital signs 
 
Pulse rate 
Blood pressure 
Temperature 
Respiratory rate 
 
Local examination 
 
Per rectal/vaginal examination 
 
Other systems 
 
Respiratory system 
Cardiovascular system 
 
Speciality opinion 
 
 
Investigations 
 
 Hb%  PCV 
 TC  DC 
 BT  CT 
 ESR  Ps 
 
Blood-grouping and typing 
 
Blood : Urea  Sugar 
Serum : Creatine Electrolytes 
 
Liver function tests : Bilurubin - Direct/Indirect 
    SAP 
    SGOT 
    SGPT 
    SR proteins 
 
CXR-Chest x-ray - PA view 
AXR-X-ray abdomen - Erect 
 
USG - Abdomen 
 Pelvis 
 
  
Special investigation 
 
 UGI scopy with biopsy 
 Barium swallow 
 CECT-Chest/Abdomen 
 MRI 
 Endoluminal ultra sonography 
 Bronchoscopy 
 HPE 
 Diagnostic Laparoscopy 
 
DIAGNOSIS: 
 
 
STAGE: 
 
 
PRE OPERATIVE PREPARATION: 
 
 
NOP: 
 
 
TREATMENT: 
 
 
POST OPERATIVE MANAGEMENT: 
 
 
 
FOLLOW UP: 
 
 
 
REFERAL: 
Coloplasty
Colon mobilisation  
Oesophageal mobilisation in neck
CA oesophagus lower third reseceted specimen  
CECT thorax - CA oesophagus middle third
CECT abdomen - CA oesophagus lower third  
CA oesophagus barium swallow  lower third
CA oesophagus barium swallow lower  third  
Oesophagus clinical endoscopic measurement
Anatomical functional and surgical measurement  
Oesophagus lymphnode station
Oesophagus blood supply  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.6
13.3
33.3
24.4 24.4
0
10
20
30
40
N
o.
 o
f p
er
ce
nt
ag
e
<30 30-40 40-50 50-60 >60
Age in years
AGE INCIDENCE
SEX INCIDCENCE
77%
23%
Male
Female
  
44.4
51.1
4.5
0 0
0
10
20
30
40
50
60
N
o.
 o
f P
er
ce
nt
ag
e
Solid Semisolid Liquid Saliva Nil
Diet
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Predisposing factors
PREDISPOSING FACTORS
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SYMPTOMATOLOGY
